| Financial Year |
March 31 2023 |
| Monetary Funds |
988,390,526.91 |
| Held-for-trading Financial Assets |
568,303,492.92 |
| Notes Receivable |
37,277,831.59 |
| Accounts Receivable |
436,204,601.48 |
| Advances to Suppliers |
13,843,785.67 |
| Other Receivables |
14,987,891.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
352,103,649.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,263,352.56 |
| Total Current Assets |
2,430,489,360.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,889,957.79 |
| Investment Properties |
6,408,963.59 |
| Fixed Assetes |
1,099,361,772.13 |
| Under-construction Projects |
125,680,540.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
267,078,584.35 |
| R&D expenses |
-- |
| Goodwill |
82,271,878.80 |
| Long-Term Deferred and Prepaid Expenses |
88,552,952.14 |
| Deferred Income Tax Assets |
17,317,279.10 |
| Other Non-Current Assets |
47,165,583.51 |
| Sub-Total of Non-Current Assets |
1,891,488,838.95 |
| Total Assets |
4,321,978,199.30 |
| Short-Term Loans |
31,891,454.60 |
| Trading Financial liabilities |
909,000.00 |
| Notes Payable |
135,862,883.27 |
| Accounts Payable |
359,918,778.59 |
| Accounts Received In Advance |
289,855.29 |
| Employee Compensation Payable |
89,732,173.04 |
| Taxes Payable |
8,326,002.24 |
| Interest Payable |
295,808.22 |
| Dividend Payable |
-- |
| Other payables |
42,527,302.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,387,629.83 |
| Other Current Liabilities |
6,897,223.68 |
| Sub-Total of Current Liabilities |
784,457,736.37 |
| Long-term Loans |
-- |
| Bonds Payable |
579,146,734.33 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
39,948,753.93 |
| Other Non-Current Liabilities |
313,600,000.00 |
| Sub-Total of Non-Current Liabilities |
1,108,235,126.58 |
| Total Liabilities |
1,892,692,862.95 |
| Paid-In Capital(Or Share Stock) |
401,011,120.00 |
| Capital Surplus |
686,113,543.17 |
| Surplus Reserve |
165,073,823.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
935,275,749.49 |
| Minority Stockholder's Interest |
210,255,502.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,219,029,834.33 |
| Owner's Equity（Stockholder's Equity） |
2,429,285,336.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,321,978,199.30 |
